Your browser doesn't support javascript.
loading
Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies.
Miyamoto, Tomoyoshi; Domoto, Risa; Sekiguchi, Fumiko; Kamaguchi, Riki; Nishimura, Rika; Matsuno, Misato; Tsubota, Maho; Fujitani, Masanori; Hatanaka, Shigekatsu; Koizumi, Yuichi; Wang, Dengli; Nishibori, Masahiro; Kawabata, Atsufumi.
Afiliación
  • Miyamoto T; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan; Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, Japan.
  • Domoto R; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan.
  • Sekiguchi F; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan.
  • Kamaguchi R; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan.
  • Nishimura R; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan.
  • Matsuno M; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan.
  • Tsubota M; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan.
  • Fujitani M; Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, Japan.
  • Hatanaka S; Department of Clinical Laboratory, Seichokai Fuchu Hospital, Izumi, Japan.
  • Koizumi Y; Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, Japan.
  • Wang D; Department of Pharmacology, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Nishibori M; Department of Translational Research and Drug Development, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Kawabata A; Laboratory of Pharmacology & Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Japan. Electronic address: kawabata@phar.kindai.ac.jp.
J Pharmacol Sci ; 148(3): 315-325, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35177211
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades del Sistema Nervioso Periférico / Enfermedad Hepática Inducida por Sustancias y Drogas / Oxaliplatino / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades del Sistema Nervioso Periférico / Enfermedad Hepática Inducida por Sustancias y Drogas / Oxaliplatino / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón